Penny Stocks to Watch: Top 10 US Stocks for September 2025

Penny stocks in the US market are gaining attention as investors seek growth opportunities amidst inflation concerns. The top 10 penny stocks in the US include Dingdong (Cayman) (DDL), Waterdrop (WDH), WM Technology (MAPS), and Puma Biotechnology (PBYI), among others. Erasca and Viomi Technology are also highlighted for their strong financial health and solid fundamentals. Investors should focus on stocks that combine strong financial health with solid fundamentals to uncover hidden gems with stability and upside potential.

Penny stocks in the US market are gaining attention as investors seek growth opportunities amidst inflation concerns. The top 10 penny stocks in the US include Dingdong (Cayman) (DDL), Waterdrop (WDH), WM Technology (MAPS), and Puma Biotechnology (PBYI), among others. Erasca and Viomi Technology are also highlighted for their strong financial health and solid fundamentals.

Investors should focus on stocks that combine strong financial health with solid fundamentals to uncover hidden gems with stability and upside potential. Dingdong (Cayman) Limited, for instance, demonstrated strong financial performance and strategic management, reporting Q2 2025 revenue of CN¥5.98 billion and net income rising to CN¥107.19 million. This growth, supported by experienced leadership and a robust balance sheet, showcases high-quality earnings and stable volatility ProKidney Leads Our Trio Of Promising Penny Stocks^[2].

ProKidney Corp., another notable penny stock, is a clinical-stage biotechnology company focused on developing a cell therapy platform for treating multiple chronic kidney diseases in the United States. Despite being debt-free and having short-term assets exceeding liabilities, it faces significant hurdles such as unprofitability and inexperienced management. However, ProKidney's ongoing Phase 3 trials for rilparencel show promise under the FDA's accelerated approval pathway, potentially influencing future growth prospects in kidney disease treatment markets ProKidney Leads Our Trio Of Promising Penny Stocks^[2].

Tuya Inc., operating as an AI cloud platform service provider in China, presents a compelling case in the penny stock realm. The company recently transitioned to profitability, reporting a Q2 2025 net income of US$12.59 million and sales of US$80.13 million, up from the previous year. Tuya boasts strong financial health with short-term assets significantly exceeding liabilities and no debt burden over the past five years. While its return on equity is low, its earnings growth trajectory is promising, supported by an experienced management team and board of directors ProKidney Leads Our Trio Of Promising Penny Stocks^[2].

In conclusion, penny stocks offer intriguing possibilities for investors seeking growth opportunities amidst inflation concerns. By focusing on stocks with strong financial health and solid fundamentals, investors can uncover hidden gems with stability and upside potential. However, it is crucial to conduct thorough research and consider the risks associated with these investments.